Integral Diagnostics

Integral Diagnostics Equity

The The Equity of Integral Diagnostics (IDX.AX) as of Sep 25, 2026 is 675.97 M AUD. In the previous year, The Equity was 693.00 M AUD — a change of -2.46% (lower).

Equity

675.97 MAUD

YoY

-2.46%

Last updated:

In 2026, Integral Diagnostics's equity was 675.97 M AUD, a -2.46% increase from the 693.00 M AUD equity in the previous year.

The Integral Diagnostics Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
127.22 M AUD
Jan 1, 2020
228.33 M AUD
Jan 1, 2021
254.74 M AUD
Jan 1, 2022
347.24 M AUD
Jan 1, 2023
373.05 M AUD
Jan 1, 2024
301.71 M AUD
Jan 1, 2025
693.00 M AUD
Jan 1, 2026
675.97 M AUD
The Integral Diagnostics Equity history
YEAREquityYoY
675.97 MAUD-2.46%
693.00 MAUD+129.69%
301.71 MAUD-19.12%
373.05 MAUD+7.43%
347.24 MAUD+36.31%
254.74 MAUD+11.57%
228.33 MAUD+79.48%
127.22 MAUD+36.18%
93.42 MAUD+3.40%
90.35 MAUD+7.66%
83.92 MAUD+100.57%
41.84 MAUD+1,340.31%
2.90 MAUD—
Access this data via the Eulerpool API

Integral Diagnostics Stock analysis

What does Integral Diagnostics do? Integral Diagnostics Ltd is an Australian company that has been providing medical imaging services for over 25 years. The company was founded in 1994 by Dr. Ian Kadish and a team of radiologists in Perth, Western Australia, offering radiology services to local clinics and hospitals. Over the years, Integral Diagnostics has expanded its services to provide imaging services nationwide. The business model of Integral Diagnostics is to deliver medical imaging to enable doctors and their patients to have a fast and accurate diagnosis. The company offers imaging services for a variety of medical specialties, including radiology, cardiology, obstetrics and gynecology, and neurology. They operate over 49 locations in Australia, many of which are in rural areas where access to medical care may be limited. Integral Diagnostics offers a wide range of products based on medical imaging. These include X-rays, mammography, ultrasound, CT scans, MRI scans, PET scans, and bone density scans. The company takes pride in being one of the few Australian medical imaging companies to offer a complete range of imaging services. Their services are conducted by qualified radiologists specialized in interpreting medical images. Integral Diagnostics also operates clinics for performing diagnostic and therapeutic procedures such as biopsies, drainages, and injections. These procedures are carried out by highly qualified radiologists to provide patients with faster and more accurate diagnoses. Integral Diagnostics is committed to quality assurance and has a comprehensive quality management system that is annually reviewed by independent auditors. The company is accredited by both the Australian Medical Association and the Australian National Accreditation Scheme (NATA). These accreditations recognize the high standards that Integral Diagnostics sets for delivering medical imaging services. One of Integral Diagnostics' recent activities is their use of artificial intelligence (AI) in image interpretation. The company has partnered with MaxQ AI, a leading provider of AI solutions for medical imaging. Through this partnership, Integral Diagnostics doctors can utilize the latest AI tools to improve their patients' diagnoses. Integral Diagnostics is a strong advocate for social justice and is dedicated to supporting disadvantaged communities in Australia. The company has partnered with nonprofit organizations such as the National Breast Cancer Foundation, The Smith Family, and the Friendship Foundation. Overall, Integral Diagnostics has undergone impressive growth over the past 25 years and is now a leading Australian medical imaging company. With a wide range of imaging services and a strong focus on quality and social responsibility, the company is well-positioned to continue its success in the future. Integral Diagnostics is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Integral Diagnostics's Equity

Integral Diagnostics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Integral Diagnostics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Integral Diagnostics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Integral Diagnostics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Integral Diagnostics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Integral Diagnostics stock

The Equity of Integral Diagnostics is 675.97 M AUD in 2026.

The Equity of Integral Diagnostics changed from 693.00 M AUD to 675.97 M AUD, representing a -2.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Integral Diagnostics since 2006 – with annual values, charts, and detailed analysis.

The Equity's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Integral Diagnostics historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Integral Diagnostics

All Key Metrics — Integral Diagnostics